-

Bredehorst Clinic Medical Management, Germany’s Leading Healthcare Procurement Specialist, partners with Sigla
DÜSSELDORF, Germany, July 1, 2026 /PRNewswire/ — Düsseldorf – Sigla, a European private equity firm, is pleased to announce its investment in Bredehorst Clinic Medical Management GmbH (“BCMM” or “the Company”), Germany’s leading provider of tech-enabled procurement optimisation services for hospitals and care facilities. BCMM improves the purchasing of German healthcare providers, particularly hospitals, by…
-
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa Hopledo® is already approved and marketed in the United States as CREXONT®, providing established regulatory and commercial experience as the therapy advances toward European approval More than…
-

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
GENEVA, June 27, 2026 /PRNewswire/ — Adults with both epilepsy and hearing loss who use hearing aids may have a 23% lower risk of developing dementia than those who do not, according to new research presented at the European Academy of Neurology (EAN) Congress 2026. Hearing loss is widely recognised as the largest modifiable risk…
-

Vusion extends partnership with JYSK Across Europe
The global leader in AI-powered digitalisation solutions renews its long-standing collaboration with the leading European home furnishings retailer Upgrade of 450 Nordic stores (~1.2m ESLs) to the latest Vusion ESL technology Expansion to 750 additional stores across Europe (~3m ESLs) Full fleet transition to VusionCloud, with scale expected to reach 2,500 stores by 2027 across the Nordics and…
-
Chiesi Global Rare Diseases Announces European Commission Approval of LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolaemia (HoFH)
European Commission approval expands the indication of lomitapide in the European Union (EU) to include children 5 years of age and older with HoFH, an ultra-rare genetic disorder affecting LDL-cholesterol levels June 05, 2026 02:00 ET | Source: Chiesi Global Rare Diseases PARMA, Italy, June 05, 2026 (GLOBE NEWSWIRE) — Chiesi Global Rare Diseases, a…
-
Pure DC Demonstrates Gas Connected Data Centres can be Decarbonised at Operational Scale with Europe’s First Large-Scale Cross-Border Biomethane Deal
Pure DC’s Dublin site decarbonised with biomethane from Germany Transaction is a 9,000-fold increase on its 2025 Proof of Concept 9GWh of RED II & III-compliant biomethane balanced from Germany to Ireland and consistent with Ireland’s Large Energy User policy and Climate Action Plan LONDON, June 03, 2026 (GLOBE NEWSWIRE) — Pure Data Centres Group…
-

Changan Automobile Announces Global Strategic Partnership with the Portugal National Football Team
“Stay in the Game” – A Shared Commitment to Excellence, Innovation, and Endurance. Lisbon, 22 May 2026 – Changan Automobile today announced a global strategic partnership with the Portuguese Football Federation (FPF), becoming the Official Global Partner of the Portugal National Football Team. The announcement ceremony took place at Cidade do Futebol, the heart of…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.









